445
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Precancerous Lesions of the Cervix and Associated Factors among Women of East Gojjam, Northwest Ethiopia, 2020

, , &
Pages 9401-9410 | Published online: 29 Dec 2021

References

  • Ludmir J, Sehdev HM. Anatomy and physiology of the uterine cervix. Clin Obstet Gynecol. 2000;43(3):433–439. doi:10.1097/00003081-200009000-0000310949747
  • Mukonoweshuro P, Oriowolo A, Smith M. Audit of the histological definition of cervical transformation zone. J Clin Pathol. 2005;58(6):671.15917428
  • Chigira M, Noda K, Watanabe H. Autonomy in tumor cell proliferation. Med Hypotheses. 1990;32(4):249–254. doi:10.1016/0306-9877(90)90101-J2172752
  • Berek JS; Berek & Novak’s Gynecology. Cervical and Vaginal Cancer. 14th ed. USA: Lippincott Williams & Wilkins; 2007.
  • Sharma K, Dubey S, Vyas S. Histopathological spectrum of cervical lesions in a tertiary health care centre. Significance. 2010;14(1):0–001.
  • Zhang T, Luo YM, Li P, et al. Cervical precancerous lesions classification using pre-trained densely connected convolutional networks with colposcopy images. Biomed Signal Process Control. 2020;55:101566. doi:10.1016/j.bspc.2019.101566
  • Federal ministry of health Ethiopia. Cervical cancer treatment and prevention guidelines; 2015.
  • Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Global Health. 2020;8(2):e191–e203. doi:10.1016/S2214-109X(19)30482-631812369
  • Nogara PRB, Manfroni LAR, da Silva MC, Consolaro MEL. The “see and treat” strategy for identifying cytologic high-grade precancerous cervical lesions among low-income Brazilian women. Int J Gynecol Obstet. 2012;118(2):103–106. doi:10.1016/j.ijgo.2012.02.017
  • Gebremariam T. Human papillomavirus related cervical cancer and anticipated vaccination challenges in Ethiopia. Int J Health Sci. 2016;10(1):137. doi:10.12816/0031220
  • Bruni LAG, Serrano B, Mena M, et al. Human papillomavirus and related diseases in Ethiopia. Summary Report ICO/IARC Information Centre on HPVand Cancer (HPV Information Centre). 2019.
  • Teka T, Kote M, Kejela G, Getachew T. Magnitude and factors associated with precervical cancer among screened women in Southern Ethiopia. Adv Public Health. 2019;2019:1–8. doi:10.1155/2019/5049752
  • de Sanjosé S, Serrano B, Castellsagué X, et al. Human papillomavirus (HPV) and related cancers in the global alliance for vaccines and immunization (GAVI) countries: a WHO/ICO HPV information centre report. A WHO/ICO HPV Information Centre Report; 2012.
  • Federal Democratic Republic of Ethiopia Ministry of Health. Health Sector Development Programme IV 2010/11 – 2014/15; 2010.
  • Abate M, Dilnessa T, Workie A, Temesgen K. Proportions of Pre-Cancerous Cervical Lesions and Its Associated Factors among Women Clients in the Age Group of 30–49yrs in Gynecology Ward of Dessie Referral Hospital and FGAE, North-East Ethiopia, 2016. J Cancer Tumor Int. 2019;1–15. doi:10.9734/jcti/2019/v9i230105
  • Kahesa C, Kjaer SK, Ngoma T, et al. Risk factors for VIA positivity and determinants of screening attendances in Dar es Salaam, Tanzania. BMC Public Health. 2012;12(1):1055. doi:10.1186/1471-2458-12-105523216752
  • Tao L, Han L, Li X, et al. Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing. BMC Public Health. 2014;14(1):1185. doi:10.1186/1471-2458-14-118525410572
  • Derbie A, Mekonnen D, Mezgebu Y, Biadglegne F. Cervical lesion detection using visual inspection with acetic acid and associated factors among ethiopian women. Ethiop Med J. 2019;2:57.
  • African Population and Health Research Center, International Agency for Research on Cancer, World Health Organization. Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy. A demonstration project in six African countries: Malawi, Madagascar, Nigeria, Uganda, the United Republic of Tanzania, and Zambia. Geneva: World Health Organization; 2012.
  • Chambuso RS, Shadrack S, Lidenge SJ, Mwakibete N, Medeiros RM. Influence of HIV/AIDS on cervical cancer: a retrospective study from Tanzania. J Glob Oncol. 2017;3(1):72–78. doi:10.1200/JGO.2015.00296428717744
  • Gedefaw A, Astatkie A, Tessema GA. The prevalence of precancerous cervical cancer lesion among HIV-infected women in Southern Ethiopia: a cross-sectional study. PLoS One. 2013;8:e84519.24376818
  • Tesfa A. Combating cervical cancer in Ethiopia. Pathfinder International/Ethiopia; 2010.
  • Zekariase G, Zemen T, Mussie Aet al. Determinant factors of visual inspection with acetic acid (via) positive lesions among hiv positive women in Mekelle hospital, Northern Ethiopia: a case control study. Ethiop Med J. 2015;53:17–24.
  • Belayneh T, Mitiku H, Weldegebreal F. Precancerous cervical lesion and associated factors among HIV-infected women on ART in Amhara Regional State, Ethiopia: a hospital-based cross-sectional study. Int J Health Sci. 2019;13(3):4.
  • Teame H, Addissie A, Ayele W, et al. Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: a case control study. PLoS One. 2018;13(1):e0191506. doi:10.1371/journal.pone.019150629352278
  • Bezabih M, Tessema F, Sengi H, Deribew A. Risk factors associated with invasive cervical carcinoma among women attending Jimma University specialized hospital, Southwest Ethiopia: a case control study. Ethiop J Health Sci. 2015;25(4):345. doi:10.4314/ejhs.v25i4.826949299
  • Brinton LA, Fraumeni JF. Epidemiology of uterine cervical cancer. J Chronic Dis. 1986;39(12):1051–1065. doi:10.1016/0021-9681(86)90139-63539967
  • Fotra R, Gupta SH, Gupta S. Sociodemographic risk factors for cervical cancer in Jammu region of Jand K state of India first ever report from Jammu. Indian J Sci Res. 2014;9(1):105.
  • Mupepi SC, Sampselle CM, Johnson TR. Knowledge, attitudes, and demographic factors influencing cervical cancer screening behavior of Zimbabwean women. J Women’s Health. 2011;20(6):943–952. doi:10.1089/jwh.2010.2062
  • Huchko MJ, Leslie H, Sneden J, et al. Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya. Int J Cancer. 2014;134(3):740–745. doi:10.1002/ijc.2840123900762
  • Getinet M, Gelaw B, Sisay A, Mahmoud EA, Assefa A. Prevalence and predictors of Pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening center at Debre Markos referral hospital, East Gojjam, Northwest Ethiopia. BMC Clin Pathol. 2015;15(1):16. doi:10.1186/s12907-015-0016-226401120
  • McFarlane-Anderson N, Bazuaye PE, Jackson MD, Smikle M, Fletcher HM. Cervical dysplasia and cancer and the use of hormonal contraceptives in Jamaican women. BMC Women’s Health. 2008;8(1):9. doi:10.1186/1472-6874-8-918513406
  • Bright PL, Norris Turner A, Morrison CS, et al. Hormonal contraception and area of cervical ectopy: a longitudinal assessment. Contraception. 2011;84(5):512–519. doi:10.1016/j.contraception.2011.02.00222018127
  • Beyene TT, Akibu M, Bekele H, Seyoum W. Determinants of precancerous cervical lesion among women screened for cervical cancer in south Ethiopia: a case-control study. Res Sq. 2019. doi:10.21203/rs.2.14781/v1
  • Ansa M, Mekonnen T. Prevalence of via positive cervical lesions and determinant factors among women attending regular gynecology outpatient department (rgopd) at Saint Paul’s hospital millennium medical college (sphmmc). Ethiop J Reprod Health. 2018;10:11.
  • Kassa LS, Dile WM, Zenebe GK, Berta AM. Precancerous lesions of cervix among women infected with HIV in Referral Hospitals of Amhara Region, Northwest Ethiopia: a cross sectional study. Afr Health Sci. 2019;19(1):1695–1704. doi:10.4314/ahs.v19i1.4631149000
  • Utoo B, Utoo P, Ngwan S, Anzaku S, Daniel M. Cervical intraepithelial neoplasia: prevalence, risk factors, and utilization of screening services among an urban population in Nigeria. Trop J Obstet Gynaecol. 2016;33(3):279. doi:10.4103/0189-5117.199810
  • Izudi J, Adrawa N, Amongin D. Precancerous cervix in human immunodeficiency virus infected women thirty years old and above in Northern Uganda. J Oncol. 2016;2016:1–7. doi:10.1155/2016/5473681
  • Chichareon S, Herrero R, Munoz N, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst. 1998;90(1):50–57. doi:10.1093/jnci/90.1.509428783
  • Plisko O, Zodzika J, Rezeberga D, et al. Associations between sexually transmitted infections and cervical precancerous lesions in Latvian women. Eur J Obstet Gynecol Reprod Biol. 2019;234:e153. doi:10.1016/j.ejogrb.2018.08.493
  • Temmerman M, Tyndall M, Kidula N, Claeys P, Muchiri L, Quint W. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV‐1 infection. Int J Gynecol Obstet. 1999;65(2):171–181. doi:10.1016/S0020-7292(99)00043-0
  • Moodley JR, Hoffman M, Carrara H, et al. HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. BMC Cancer. 2006;6(1):135. doi:10.1186/1471-2407-6-13516719902
  • Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst. 1995;87(11):796–802. doi:10.1093/jnci/87.11.7967791229